This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice.
A new preprint design is coming!
We have improved readability, clarity, accessibility, and opportunities for engagement.
Research Article
License:
This work is licensed under a CC BY 4.0 License. Read Full License
It is well known that Breast cancer is a heterogeneous disease.Although the current recurrence and mortality rate have been greatly improved, many people still suffer relapse and metastasis.Metabolic reprograming is currently considered to be a new hallmark of cancer.Therefore,in this study, we comprehensively analyzed the prognostic effect of metabolic-related gene signatures in breast cancer and its relationship with the immune microenvironment.We constructed a novel metabolic-related gene signature containing 6 genes to distinguish between high and low risk groups by univariate Cox regression and least absolute shrinkage and selection operator (LASSO) regression, and validated its robustness and accuracy through multiple databases.
The metabolic gene signature may be an independent risk factor for BC both in the training and the testing set,the nomogram has a moderately accurate performance,and the C index was 0.757 and 0.728 respectively.The signature can reveal metabolic characteristics based on gene set enrichment analysis and at the same time monitor the status of TME.This gene signature can be used as a promising independent prognostic marker for BC patients, and can indicate the current status of TME, providing more clues for exploring new diagnostic and treatment strategies.
Keywords
metabolic signature,tcga,geo,breast cancer，TME
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9
Figure 10
Figure 11
Loading...
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
History
CURRENT STATUS: Posted
The most recent version of this article is available here.
No community comments so far
Version 1
Posted 22 Feb, 2021
No comments provided
Metrics
Comments: 0
PDF Downloads: ...
HTML Views: ...
Learn more about our company.
A new preprint design is coming!
We have improved readability, clarity, accessibility, and opportunities for engagement.
This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice.
Research Article
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
History
CURRENT STATUS: Posted
The most recent version of this article is available here.
No community comments so far
Version 1
Posted 22 Feb, 2021
No comments provided
Metrics
Comments: 0
PDF Downloads: ...
HTML Views: ...
License:
This work is licensed under a CC BY 4.0 License. Read Full License
The most recent version of this article is available here.
It is well known that Breast cancer is a heterogeneous disease.Although the current recurrence and mortality rate have been greatly improved, many people still suffer relapse and metastasis.Metabolic reprograming is currently considered to be a new hallmark of cancer.Therefore,in this study, we comprehensively analyzed the prognostic effect of metabolic-related gene signatures in breast cancer and its relationship with the immune microenvironment.We constructed a novel metabolic-related gene signature containing 6 genes to distinguish between high and low risk groups by univariate Cox regression and least absolute shrinkage and selection operator (LASSO) regression, and validated its robustness and accuracy through multiple databases.
The metabolic gene signature may be an independent risk factor for BC both in the training and the testing set,the nomogram has a moderately accurate performance,and the C index was 0.757 and 0.728 respectively.The signature can reveal metabolic characteristics based on gene set enrichment analysis and at the same time monitor the status of TME.This gene signature can be used as a promising independent prognostic marker for BC patients, and can indicate the current status of TME, providing more clues for exploring new diagnostic and treatment strategies.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9
Figure 10
Figure 11
Loading...